Research peptide
Retatrutide
Few metabolic tool compounds engage as many pathways at once as Retatrutide. This synthetic peptide acts as a triple incretin receptor agonist, hitting the GLP-1, GIP and glucagon receptors in parallel — a mechanism that places it among the most intricate agonists available for preclinical metabolic signalling work. Supplied as a lyophilised powder across six vial sizes, every batch reaches ≥99% purity confirmed by HPLC, with a Certificate of Analysis available on request. Dispatched from a UK-based facility for laboratory and research use only. Research applications Simultaneous GLP-1R / GIPR / glucagon receptor agonism assays Energy homeostasis and metabolic pathway modelling Receptor engagement comparisons against single- and dual-agonist peptides Gut-brain axis and appetite-signalling investigations Specifications Form: Lyophilised powder Purity: ≥99% (HPLC verified) Storage: −20°C, protected from light and moisture Available sizes: 10mg · 20mg · 30mg · 40mg · 50mg · 60mg Certificate of Analysis: available on request
Size: 10mg
Multi-buy discount available
- Buy 2Save 5%
- Buy 3Save 10%
- Buy 5Save 15%
- Buy 10Save 20%
- 99%+ purity guaranteed
- COA available
- Same-day dispatch
- Secure checkout
Product details
- Retatrutide receptor binding and agonism assays in controlled laboratory settings.
- In vitro pathway signalling studies requiring batch-documented research material.
- Analytical method development and HPLC reference characterisation.
- Institutional protocol workstreams that require published Certificates of Analysis.
